Found 12 matching trials
BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma PHASE2 This is a multi-center, prospective study. The main purpose is to evaluate ...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZL PHASE2 In patients with previously untreated Marginal zone lymphoma (MZL), a treat...
Show More Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing,
Learn More & Join Trial
A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy PHASE2 This study is a multicenter, randomized, open label, cyclosporine controlle...
Show More Status
Active Not Recruiting
Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia PHASE1 This study aims to utilize anti-CD20 monoclonal antibodies to eliminate per...
Show More Location
Multiple Locations
Learn More & Join Trial
Zuberitamab for EBV Infection Post-Allo-HSCT PHASE2 EBV DNAemia is defined as the presence of EBV-DNA load in peripheral blood ...
Show More Location
Multiple Locations
Learn More & Join Trial
Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma PHASE2 This is a single-center, single-arm, prospective study aimed at evaluating ...
Show More Location
The First Bethune Hospital of Jilin University
Learn More & Join Trial
Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma NA This multicenter trial evaluates the efficacy and safety of pomalidomide co...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial PHASE4 For relapsed/refractory mantle cell lymphoma patients that previously treat...
Show More Location
The first affiliated hospital of Zhengzhou University
Learn More & Join Trial
Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome PHASE3 The goal of this clinical trial is to learn whether adding Zuberitamab to s...
Show More Location
Children's Hospital of Fudan University
Learn More & Join Trial
Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma PHASE2 This is a multi-center, phase II, prospective study. The main purpose of st...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial